AngioDynamics Inc (ANGO) stock
ANGONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends May 31
Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 8, 2026Score 12/3011% below fair value
$11.49−0.29 (-2.46%)
Close on Nov 17, 2026Market cap $483.21MP/E –Yield –
AngioDynamics operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
AngioDynamics's operating income for the twelve months ending Aug 31, 2026 was -$36.57M. For fiscal 2026 it was -$39.93M. The highest annual figure on record is $20.87M in fiscal 2010.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | May 31, 2026 | -$39.93M | – |
| FY2025 | May 31, 2025 | -$39.95M | – |
| FY2024 | May 31, 2024 | -$192.44M | – |
| FY2023 | May 31, 2023 | -$51.18M | – |
| FY2022 | May 31, 2022 | -$28.47M | – |
| FY2021 | May 31, 2021 | -$35.28M | – |
| FY2020 | May 31, 2020 | -$167.10M | – |
| FY2019 | May 31, 2019 | -$9.40M | – |
| FY2018 | May 31, 2018 | -$14.17M | – |
| FY2017 | May 31, 2017 | -$11.18M | -1197.7% |
| FY2016 | May 31, 2016 | $1.02M | – |
| FY2015 | May 31, 2015 | -$3.45M | -132.9% |
| FY2014 | May 31, 2014 | $10.49M | +100.1% |
| FY2013 | May 31, 2013 | $5.24M | – |
| FY2012 | May 31, 2012 | -$5.24M | -144.1% |
| FY2011 | May 31, 2011 | $11.90M | -43.0% |
| FY2010 | May 31, 2010 | $20.87M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ3 2026 | Aug 31, 2026 | -$7.30M | – |
| Q4 FY2026CQ2 2026 | May 31, 2026 | -$10.20M | – |
| Q3 FY2026CQ1 2026 | Feb 28, 2026 | -$12.95M | – |
| Q2 FY2026CQ4 2025 | Nov 30, 2025 | -$6.13M | – |
| Q1 FY2026CQ3 2025 | Aug 31, 2025 | -$10.66M | – |
| Q4 FY2025CQ2 2025 | May 31, 2025 | -$5.79M | – |
| Q3 FY2025CQ1 2025 | Feb 28, 2025 | -$9.97M | – |
| Q2 FY2025CQ4 2024 | Nov 30, 2024 | -$11.09M | – |
| Q1 FY2025CQ3 2024 | Aug 31, 2024 | -$13.10M | -137.4% |
| Q4 FY2024CQ2 2024 | May 31, 2024 | -$14.45M | – |
| Q3 FY2024CQ1 2024 | Feb 29, 2024 | -$199.90M | – |
| Q2 FY2024CQ4 2023 | Nov 30, 2023 | -$13.12M | – |
| Q1 FY2024CQ3 2023 | Aug 31, 2023 | $35.03M | – |
| Q4 FY2023CQ2 2023 | May 31, 2023 | -$20.84M | – |
| Q3 FY2023CQ1 2023 | Feb 28, 2023 | -$8.93M | – |
| Q2 FY2023CQ4 2022 | Nov 30, 2022 | -$8.12M | – |
| Q1 FY2023CQ3 2022 | Aug 31, 2022 | -$13.30M | – |
| Q4 FY2022CQ2 2022 | May 31, 2022 | -$6.40M | – |
| Q3 FY2022CQ1 2022 | Feb 28, 2022 | -$5.30M | – |
| Q2 FY2022CQ4 2021 | Nov 30, 2021 | -$8.68M | – |
| Q1 FY2022CQ3 2021 | Aug 31, 2021 | -$8.10M | – |
| Q4 FY2021CQ2 2021 | May 31, 2021 | -$21.59M | – |
| Q3 FY2021CQ1 2021 | Feb 28, 2021 | -$3.74M | – |
| Q2 FY2021CQ4 2020 | Nov 30, 2020 | -$4.84M | – |
| Q1 FY2021CQ3 2020 | Aug 31, 2020 | -$5.12M | – |
| Q4 FY2020CQ2 2020 | May 31, 2020 | -$156.61M | -5439.6% |
| Q3 FY2020CQ1 2020 | Feb 29, 2020 | -$6.24M | – |
| Q2 FY2020CQ4 2019 | Nov 30, 2019 | -$3.42M | – |
| Q1 FY2020CQ3 2019 | Aug 31, 2019 | -$828.00K | – |
| Q4 FY2019CQ2 2019 | May 31, 2019 | $2.93M | – |
| Q3 FY2019CQ1 2019 | Feb 28, 2019 | -$3.67M | -175.6% |
| Q2 FY2019CQ4 2018 | Nov 30, 2018 | -$2.53M | -325.0% |
| Q1 FY2019CQ3 2018 | Aug 31, 2018 | -$6.13M | -4477.9% |
| Q4 FY2018CQ2 2018 | May 31, 2018 | -$20.29M | – |
| Q3 FY2018CQ1 2018 | Feb 28, 2018 | $4.86M | -5.4% |
| Q2 FY2018CQ4 2017 | Nov 30, 2017 | $1.12M | -92.8% |
| Q1 FY2018CQ3 2017 | Aug 31, 2017 | $140.00K | – |
| Q4 FY2017CQ2 2017 | May 31, 2017 | -$35.48M | – |
| Q3 FY2017CQ1 2017 | Feb 28, 2017 | $5.14M | – |
| Q2 FY2017CQ4 2016 | Nov 30, 2016 | $15.59M | – |
See a number that looks wrong?